Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: A large cross-sectional study

Table 2 Comparison of clinical data between Helicobacter pylori-positive and Helicobacter pylori-negative groups within the metabolic dysfunction-associated steatotic liver disease cohort

Parameter	H. pylori-negative group (n = 7424)	H. pylori-positive group (n = 2845)	t value	P value
Age (year)	48.39 ± 13.77	48.91 ± 13.19	-1.76	0.79
Blood glucose	5.60 ± 1.60	5.82 ± 1.95	-5.3	0.001
HDL (mmol/L)	1.23 ± 0.30	1.22 ± 0.30	1.31	0.191
Total cholesterol (mmol/L)	5.00 ± 1.00	5.05 ± 1.03	-2.07	0.039
Triglycerides (mmol/L)	2.27 ± 1.99	2.30 ± 1.91	-0.404	0.686
LDL (mmol/L)	3.13 ± 0.75	3.16 ± 0.76	-1.78	0.076
BMI (kg/m²)	26.04 ± 2.96	26.23 ± 3.00	-2.88	0.004
Systolic blood pressure (mmHg)	128.49 ± 17.62	129.5 ± 20.00	-2.6	0.009
Diastolic blood pressure (mmHg)	79.04 ± 11.76	79.87 ± 12.07	-3.16	0.002
Gender (male/female)	5538/1886	2075/770	χ2 = 2.9591	0.85

¹The test method for this item is the χ² test.

Data are presented as the mean ± SD or n (%). Continuous variables were analyzed via the Student’s t-test; categorical variables were analyzed via the χ² test. H. pylori: Helicobacter pylori; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; BMI: Body mass index.